2010
DOI: 10.1074/jbc.m110.155317
|View full text |Cite
|
Sign up to set email alerts
|

Heat Shock Protein 90 as a Drug Target against Protozoan Infections

Abstract: Using a pharmacological inhibitor of Hsp90 in cultured malarial parasite, we have previously implicated Plasmodium falciparum Hsp90 (PfHsp90) as a drug target against malaria. In this study, we have biochemically characterized PfHsp90 in terms of its ATPase activity and interaction with its inhibitor geldanamycin (GA) and evaluated its potential as a drug target in a preclinical mouse model of malaria. In addition, we have explored the potential of Hsp90 inhibitors as drugs for the treatment of Trypanosoma inf… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

9
134
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
5
2
2

Relationship

1
8

Authors

Journals

citations
Cited by 145 publications
(143 citation statements)
references
References 42 publications
9
134
0
Order By: Relevance
“…In order to determine whether decrement of mitochondrial replication is specific to radicicol treatment, we performed a similar study by exposing the parasites with 17AAG, a potent Hsp90 inhibitor. It was previously reported that 17AAG inhibits the growth of 3D7 with an IC 50 of 160 nM when treated for 48 h (24). With our experimental conditions, we determined the IC 50 of 17AAG as 170 nM, which is very close to the previously reported value.…”
Section: Resultssupporting
confidence: 76%
“…In order to determine whether decrement of mitochondrial replication is specific to radicicol treatment, we performed a similar study by exposing the parasites with 17AAG, a potent Hsp90 inhibitor. It was previously reported that 17AAG inhibits the growth of 3D7 with an IC 50 of 160 nM when treated for 48 h (24). With our experimental conditions, we determined the IC 50 of 17AAG as 170 nM, which is very close to the previously reported value.…”
Section: Resultssupporting
confidence: 76%
“…Moreover, protozoan Hsp90 differs in biochemical characteristics from Hsp90 of the mammalian host. For example, Hsp90 from P. falciparum exhibits about six times higher ATPase activity than its human counterpart (34,62). Furthermore, the ATP-binding pocket of E. histolytica Hsp90 may mediate unique ligand interactions, based on the presence of Cys49 and Arg109 relative to the corresponding Ser52 and Lys112 in the human Hsp90 ATP-binding domain.…”
Section: Discussionmentioning
confidence: 99%
“…Hsp90 is implicated in growth and development in many protozoan species, including Dictyostelium, Leishmania, Plasmodium, Trypanosoma, and Giardia species (31)(32)(33)(34)(35). Inhibition of parasite Hsp90 activity by geldanamycin resulted in lethality in Plasmodium fal-ciparum (36), but this compound has not been pursued for clinical development due to unacceptable toxicity.…”
Section: T He Protozoan Intestinal Parasites Entamoeba Histolytica Andmentioning
confidence: 99%
“…In addition to its ability to fold proteins and regulate cell cycle and development, recent studies also suggest an ability to guide evolution in eukaryotes (11-13). The function of Hsp90 as a sensor of environmental cues is especially crucial in protozoan parasites, which often need to respond to radical changes of milieus within and outside their hosts (7,10).In all organisms investigated to date, Hsp90 proteins are encoded by a single open reading frame (ORF), which usually contains multiple introns. In the genome sequence of three Giardia isolates, no contiguous hsp90 ORF was predicted, but two fragments separated by a large stretch of sequence on the same scaffold were detected and annotated as hsp90.…”
mentioning
confidence: 99%